Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IBIO

iBio (IBIO)

iBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:IBIO
DateTimeSourceHeadlineSymbolCompany
03/27/20247:00AMGlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
03/26/20247:35PMGlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
02/26/20247:59AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
02/26/20247:45AMGlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
02/21/20244:55PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
01/19/20244:36PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
01/16/20248:15AMGlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
01/10/20241:24PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
01/08/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
01/04/20248:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
12/26/20237:44AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
12/26/20237:15AMGlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
12/08/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
12/06/20239:13AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
12/06/20238:59AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
12/05/20238:00AMGlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
12/05/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
11/30/20238:55AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
11/28/20238:36AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
11/27/20235:20PMGlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
11/03/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
11/01/20238:24AMGlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
10/27/20234:29PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
10/26/20238:22AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
10/26/20238:20AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:IBIOiBio Inc
10/16/20234:59PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:IBIOiBio Inc
10/10/20238:56AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
10/10/20238:00AMGlobeNewswire Inc.iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of BiologicsAMEX:IBIOiBio Inc
10/05/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
10/05/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
 Showing the most relevant articles for your search:AMEX:IBIO